Concord Medical Services ADR Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
No analyst estimates are published for this company.
Coverage varies across the market: larger companies are often followed by dozens of analysts, while smaller or recently listed ones may have none.
Reporting Calendar
| Event | Expected Date |
|---|---|
| 2026 Annual General Meeting of Shareholders | 29 Dec 2026 |
Monitoring Framework
Key Performance Indicators
Hospital Business Net Revenue Annually153M
Network Business Net Revenue Annually47.6M
Gross Loss Margin Annually2.1%
Watch Items
- Guangzhou Concord Cancer Hospital Proton Therapy OperationsTrigger: Ramp-up of patient volume and treatment sessionsAction: Monitor operational efficiency and contribution to hospital segment gross margin improvements.
- Liquidity and Debt Refinancing RisksTrigger: Bank loans and borrowings exceeding RMB 3.6 billionAction: Track new equity and debt financing rounds, and cash remittance from PRC subsidiaries to the Cayman Islands holding company.
Research as of 20 Jun 2026